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E-mail address: luisa.romao@insa.min-saude.pt (L.Nonsense-mediated mRNA decay (NMD) degrades mRNAs carrying premature translation termina-
tion codons (PTCs). Although the core process and several NMD effectors are conserved among spe-
cies, the involvement of a splicing-dependent signal seems to be speciﬁc for mammalian PTC
deﬁnition. Still, recent data shed new light on physical parameters and mechanistic pathways
involved in NMD. Here, we examine these ﬁndings, updating the roles for potential NMD players,
such as the exon junction complex and the cytoplasmic poly(A)-binding protein 1 – the former act-
ing as enhancer rather than an essential factor and the latter functioning as NMD repressor.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Eukaryotic gene expression consists of a multistep pathway that
involves a series of highly regulated and interconnected events in
which the mRNA plays a vital role. Individual transcripts associate
with particular protein combinations forming the messenger ribo-
nucleoprotein particles (mRNPs) [1]. The content of the mRNPs dic-
tates mRNA fate, evolving dynamically throughout the transcript
lifetime and responding to diverse cellular signal networks. Such
plasticity is highly important for cellular homeostasis, because it
provides the means to regulate gene expression at the post-tran-
scriptional level, allowing the cells to rapidly adapt to changes in
their environment by altering the patterns of gene expression
[1]. However, with each level of complexity in this multistep pro-
cess comes a higher probability for error. Therefore, for such a
highly structured and regulated system to be viable, the quality
and ﬁdelity of mRNA metabolism has to be assured. Such tight
mRNA quality control is ensured by a number of ‘‘surveillance”
mechanisms that acting at several steps of mRNA biogenesis, are
able to detect and degrade defective and improperly-processed
transcripts [2]. The most well characterized surveillance mecha-
nism is called nonsense-mediated mRNA decay (NMD). This mech-
anism detects mRNAs harboring premature termination codons
(PTCs) and commits these transcripts to rapid decay.chemical Societies. Published by E
Romão).One physiological purpose of the NMD mechanism is to limit
the synthesis of C-terminally truncated polypeptides, protecting
the cell from its deleterious dominant-negative or gain-of-function
effects [2–5]. The importance of NMD as a cell surveillance mech-
anism is pointed up by the fact that approximately 30% of inherited
genetic disorders are due to PTCs, most of which are NMD targets
[3]. Hence, the majority of nonsense-associated diseases are caused
either by insufﬁcient levels of functional proteins that can result
from degradation of the PTC-containing mRNAs by NMD or by
the inability of the abnormally PTC-containing mRNAs, which are
able to escape NMD, to generate full-length functional proteins [3].
PTC-containing mRNAs can either be generated by various types
of germline/somatic alterations in the DNA or be originated as a re-
sult of routine errors during transcription or mRNA processing
[3,7]. Nevertheless, PTCs can also arise as a consequence of non-
faulty regulated processes of the mRNA metabolism such as so-
matic rearrangements in the DNA, alternative splicing or utiliza-
tion of alternative AUG initiation sites. Also, several wild-type
transcripts can harbor UGA codons encoding selenocysteine, up-
stream open reading frames (uORFs) or an intron within the
3’UTR, all of which may lead to their recognition as PTC-containing
transcripts [3,6]. Therefore, besides its important role in cell sur-
veillance, it has become clear that the NMD mechanism also plays
a role in regulating the steady-state level of a set of wild-type tran-
scripts [7]. Several of these so-called natural NMD targets have
been identiﬁed by genome-wide DNA microarray expression pro-
ﬁling, revealing that the expression of approximately 5–10% oflsevier B.V. All rights reserved.
500 A.L. Silva, L. Romão / FEBS Letters 583 (2009) 499–505the transcriptome of yeast, Drosophila melanogaster and human
cells is regulated by the NMD mechanism [6,8–10].
The discovery of the NMD pathway has provided an explanation
for the long-lasting observation that cells degrade PTC-containing
mRNAs. In fact, NMD is an evolutionary conserved mechanism
found to be implicated in surveillance and regulation of gene
expression in all eukaryotes examined so far [7]. However,
although the general mechanism and functional implications are
conserved among different species, important differences have
been identiﬁed concerning the mechanism of PTC deﬁnition as well
as the speciﬁc degradation pathways of target transcripts [11].
While translation is considered to be a general requirement for
PTC deﬁnition, the second signal that leads to the recognition of
the translation termination event as premature appears to vary
across species. Indeed, only in mammalian cells a splicing-depen-
dent signal seems to be involved in PTC deﬁnition [11].
2. Splicing and a role for the EJC(s) on NMD
Even before the identiﬁcation of the NMD molecular players, a
rule for the recognition of PTCs that induce mammalian NMD
was postulated. Studies in mammalian systems led to the observa-
tion that PTCs, when located more than 50–54 nucleotides (nt) up-
stream the last exon–exon junction, were able to target mRNA for
decay whereas, PTCs located downstream of this boundary were
not [12]. This observation supports the view that PTC recognition
is dependent on the deﬁnition of the exon–exon junctions, suggest-
ing that the process of splicing is implicated in mammalian NMD.
In fact, several other evidence implicated splicing in mammalian
NMD: the deletion of all introns in TPI (triosephosphate isomerase)
and b-globin genes was shown to preclude NMD in these tran-
scripts [13–15] and the insertion of an intron more than 50 nt
downstream the normal stop codon makes these transcripts
NMD-competent [16]. Also, supporting a role for splicing in mam-
malian NMD, it was observed that the NMDmechanism is not acti-
vated by nonsense transcripts that are generated from naturally
intronless genes, such as histone H4, heat shock protein 70 or mel-
anocortin 4-receptor genes [17,18].
The dependence of PTC recognition on splicing and translation,
raised the question of how could these two mechanisms act to-
gether in the NMD activation. It was therefore hypothesized that
a ‘‘mark” could be assembled during splicing near the exon–exon
junctions. This mark would communicate to the NMD machinery
the location of the translation termination event relative to the
splice junctions. Presently, it is known that during pre-mRNA splic-
ing, protein complexes, called exon junction complexes (EJC),
assemble 20–24 nt upstream of each exon–exon junction [19].
The EJC is a dynamic structure with a heterogeneous protein com-
position that evolves throughout the mRNA life cycle. Some of the
EJC components identiﬁed to date include the splicing-related pro-
teins RNPS1, SRm160, Pinin and UAP56 (which is also involved in
mRNA export), the mRNA export-related proteins Aly/REF and
TAP, and the heterodimer Y14:MAGOH, as well as the BTZ and eI-
F4AIII, that appear to be involved in mRNA localization, at least in
D. melanogaster. These four latter proteins remain associated with
spliced mRNAs after their export to the cytoplasm and are thought
to constitute the stable EJC core. The remaining proteins, together
with RNA-binding protein PYM, as well as the proteins ACINUS and
SAP18, constitute a group of EJC factors that associate more tran-
siently with the mRNP, either during EJC assembly or during sub-
sequent processes of mRNA metabolism [4,19–21]. In addition,
the EJC complex was shown to constitute a binding platform for
the NMD effectors UPF2 and UPF3 (up-frameshift) [20,22]. More-
over, some of the EJC components have also been directly impli-
cated in the NMD mechanism. In fact, the EJC proteins RNPS1,Y14, MAGOH and PYM have been shown to elicit NMD when arti-
ﬁcially tethered to the 3’UTR of b-globin transcripts, at more than
50 nt downstream of the native stop codon [23–25]. Also, depletion
of Y14, eIF4AIII or BTZ by RNA interference (RNAi) was shown to
impair NMD activation on PTC-containing transcripts [24,26].
Albeit the collected set of data that implicate the EJC on mam-
malian NMD, this mechanism was also shown to be triggered with-
out the requirement of an EJC downstream of the PTC. Of these, are
examples the transcripts of b-hexosaminidase, Igl and hybrid
mouse/human b-globin [14,27,28]. For Igl transcripts, in particu-
lar, it was shown that PTCs at the penultimate exon remain
NMD-competent when the furthest downstream intron is deleted
impeding the deposition of the last downstream EJC [28]. In addi-
tion, wild-type Igl minigene, b-globin or TPI transcripts were
shown to become NMD targets provided that the 3’UTRs were ex-
tended in length [28,29]. Conversely, it was also shown that 3’UTR
introns are not sufﬁcient for triggering human NMD: the insertion
of an intron (that had been previously shown to be able to recruit
an EJC) downstream the native termination codons of b-globin or
TPI mRNAs, failed to induce NMD in these transcripts [11]. All to-
gether, these data challenge the notion that, in mammalian sys-
tems, EJCs are essential for PTC deﬁnition and NMD activation
and point out a more basic mechanism for PTC deﬁnition that
might have been conserved through the evolution.3. The NMD effectors: the UPF proteins
The UPF proteins have been considered the conserved core of
the NMD machinery, despite the organism or the mechanism by
which PTCs are deﬁned [11]. Three UPF proteins (UPF1, UPF2 and
UPF3) were ﬁrst identiﬁed in Saccharomyces cerevisiae and shown
to be essential trans-acting factors for NMD [11]. Four orthologs
of yeast UPF proteins termed hUPF1, hUPF2, hUPF3a and hUPF3b
were identiﬁed in humans [31–33]. The hUPF1 is both an ATP-
dependent 50 ? 30 helicase and an RNA-dependent ATPase, whose
activation by phosphorylation is necessary for NMD triggering
[34–36]. hUPF2 contains several putative nuclear localization sig-
nals (NLS) as well as three predicted MIF4G domains, which are
found in several proteins involved in mRNA processing and matu-
ration [31–33]. The identiﬁcation of two distinct domains on
hUPF2 that are, respectively involved in the binding of hUPF1
and hUPF3, indicates that hUPF2 can function as an adapter for
the interaction between these two factors [37]. In humans, two
genes encode the homologous proteins hUPF3a and hUPF3b
[31,33]. Both proteins are characterized by a conserved domain
with some similarity to an RNA recognition motif (RRM) [31].
Although this kind of domains is commonly involved in RNA-bind-
ing, neither hUPF3a nor hUPF3b were shown to bind directly to
RNA [37].
Several lines of evidence support the role of the human UPF pro-
teins in NMD [31–33,38]. NMD activation is impaired by the
expression of a dominant-negative hUPF1 mutant, which contains
a point mutation (R844C) in its RNA helicase domain [38]. In addi-
tion, the depletion of hUPF1, hUPF2 or hUPF3b by RNAi was shown
to inhibit NMD [39,40]. Furthermore, each of the four hUPF pro-
teins was shown to induce NMD when tethered to the 3’UTR of
b-globin mRNA [31]. Nevertheless, the two homologues hUPF3
proteins differ in their ability to elicit NMD: when tethered down-
stream of a normal stop codon, UPF3b shows a strong NMD trigger-
ing effect whereas hUPF3a has only modest activity [31,41].
There are several lines of evidence that support the association
between the four hUPF factors: co-immunoprecipitation assays
show that, in mammalian cells, hUPF1, hUPF2 and hUPF3 (a or b)
interact in a way that does not require the presence of RNA
A.L. Silva, L. Romão / FEBS Letters 583 (2009) 499–505 501[31,33]. Additionally, it was shown that hUPF2 can interact directly
and independently with both hUPF1 and hUPF3 [31–33,37].
Although the conserved core of the NMD machinery has been
considered to rely on the complex formed by UPF1, UPF2 and
UPF3, some recent data indicate that this might be not always
the case. The existence of an UPF2-independent NMD pathway
was ﬁrst suggested when tethered UPF3b mutants lacking the do-
main of interaction with UPF2 were shown able to elicit NMD [41].
This result was further highlighted by evidence suggesting that
EJCs might have two alternative compositions, both capable of eli-
cit NMD in human cells, specifying an UPF2-dependent and an
UPF2-independent pathway [42]. Still, both pathways were shown
to involve UPF3b and require UPF1 [42]. Corroborating these data,
the analysis of gene expression proﬁles of HeLa cells revealed two
subsets of putative NMD targets that, although regulated by UPF1,
diverge on their requirement for UPF2 [42].
Another alternative pathway for NMD triggering that does not
require UPF3a or UPF3b, was also pointed out. In contrast to what
has been described for b-globin and TPI transcripts, the NMD re-
sponse induced by PTC-containing TCR-b mRNAs was shown not
to be affected by RNAi-mediated depletion of UPF3b, UPF3a or both
[43]. Also, a subset of putative NMD substrates was identiﬁed that
are regulated by UPF1 but insensitive to UPF3b depletion [43]. Con-
sistent with these ﬁndings, it was recently described that naturally
occurring, inactivating mutations on UPF3b do not impair NMD
activation in humans [44]. In summary, there are pathways for
NMD triggering that can, apparently, diverge on the requirement
for UPF2, UPF3 and other EJC components. It remains to be
determined whether these constitute regular pathways or reﬂect
transcript- or cell type-speciﬁc processes. All these pathways, how-
ever, have in common the requirement for UPF1.4. UPF1 and NMD activation
UPF1 is a phosphoprotein [35] whose activity in multicellular
organisms is regulated by cycles of phosphorylation and dephos-
phorylation [11]. There are four proteins that have been shown
to play an important role in mediating the phosphorylation/
dephosphorylation cycles of UPF1: those proteins were ﬁrst identi-
ﬁed in Caenorhabditis elegans as SMG-1, SMG-5, SMG-6 and SMG-7
(SMG stands for suppressor with morphogenetic effect on genita-
lia) and their human orthologs (hSMG-1, -5, -6, and -7) were later
described and shown to share similar features [11].
SMG-1 is a phosphatidylinositol 3-kinase-related protein kinase
that was shown to phosphorylate UPF1 at speciﬁc serine residues
[35]. The SMG-5, SMG-6 and SMG-7 proteins, although not pos-
sessing phosphatase activity, were shown to promote UPF1
dephosphorylation, possibly by mediating the recruitment and
activity of PP2A (protein phosphatase 2A), which is thought to be
the protein factor responsible for UPF1 dephosphorylation
[11,36,45].
Some insights regarding the mechanism that links UPF1 to NMD
activation were provided by the study of SMG-7. This protein was
shown to speciﬁcally co-immunoprecipitate with the phosphory-
lated form of UPF1 [36]. This interaction is likely to be mediated
by hSMG-7 14-3-3 like domain, an N-terminal motif with con-
served features of a binding site for phosphoserine residues [46].
Besides SMG-7, the 14-3-3 like domain is also present in SMG-5
and SMG-6 [46], indicating that all three proteins bind phosphory-
lated UPF1. Thus, it was reasoned that these proteins may function
as adaptors in the interaction between phosphorylated UPF1 and
PP2A, thereby triggering UPF1 dephosphorylation [36,45]. In addi-
tion, SMG-7was shown to elicit mRNA decay, when artiﬁcially teth-
ered on a reporter transcript, independently of its position
relatively to the stop codon. Moreover, this effect was also achievedeven when the C-terminal region of SMG-7, which lacks the phos-
phoserine-binding domain, was used [47]. This indicates that
SMG-7 ability to trigger mRNA degradation is independent of its
interaction with UPF1 and PTC recognition. Therefore, SMG-7 ap-
pears to have two distinct domains, one that links this protein to
the surveillance complex, via its interactionwith UPF1, and another
domain that somehow is sufﬁcient to elicit mRNA decay. Tethered
SMG-5, on the other hand, requires the interaction with SMG-7 to
be able to induce mRNA decay [47]. This suggests that SMG-7 pro-
vides a molecular link between the surveillance and themRNA deg-
radation machineries [11]. In fact, the ability of SMG-7 to promote
mRNA degradation was shown to rely on the activity of DCP2 and
XRN1 (enzymes involved in decapping and exonucleolytic 50 ? 30
mRNA degradation, respectively) [47]. Accordingly, SMG-7, SMG-
5 andUPF1 aswell as proteins that function in the 50 ? 30 mRNAde-
cay pathway were found to be present in P-bodies (mRNA-process-
ing bodies), which are discrete cytoplasmic foci present in
eukaryotic cells where proteins involved in several processes of
mRNA metabolism were found to localize [47]. It was also recently
reported that UPF1 dephosphorylation occurs in P-bodies, and a
blockage in UPF1 dephosphorylation results in the accumulation
of UPF1, as well as other NMD factors and NMD substrates, in these
structures [48]. SMG-6, however, does not localize to P-bodies and
was shown to have degradation activity on single-stranded RNA
in vitro [47,49], suggesting that this factor can provide the NMD
machinery with an intrinsic nuclease activity that might account
to the rapid decay of PTC-containing mRNAs. In fact, it was recently
shown that SMG-6, besides being the endonuclease responsible for
degradation of nonsense transcripts in D. melanogaster, also con-
tributes to the degradation of PTC-containing mRNAs in human
cells [50]. It remains to be determined whether SMG-6-dependent
decay constitutes an alternative degradation pathway or acts to-
gether with SMG-5/SMG-7 along a common pathway.
Although the regulation of UPF1 phosphorylation/dephospho-
rylation cycles is thought to be critical for NMD triggering in mam-
mals, the mechanism that couples this process with PTC
recognition and surveillance complex assembly remains to be com-
pletely clariﬁed. Kashima and co-workers [51], by using co-immu-
noprecipitation analysis in human cell extracts, showed that UPF1
associates with the translation termination factors eRF1 and eRF3,
forming a single complex that also contains SMG-1, which they
called SURF (SMG-1/UPF1/eRFs). These authors also showed that
SURF can be formed independently of its interaction with the
UPF2/EJC complex, accumulating under these conditions. This sup-
ports that SURF is a transient complex that assembles on the termi-
nating ribosome before it interacts with UPF2/EJC components. The
authors also reasoned that interaction between SURF and EJC
would result in the assemblage of a major complex which was
called DECID (decay-inducing complex), probably mediated by
the interaction between UPF1 (in the SURF complex) with UPF2
(associated with the EJC). Finally, their results also suggest that
the formation of DECID can somehow activate SMG-1 to phosphor-
ylate UPF1. Interestingly, it was recently shown that hUPF1 phos-
phorylation decreases translation initiation of NMD targets [52].
It was proposed that this translational repression, by precluding
additional ribosome loading, will promote the mRNP remodeling
that makes the transcript physically accessible to degradation
activities [52]. Nevertheless, while UPF1 phosphorylation seems
to be mandatory for NMD, the requirement of a synchronized ac-
tion of UPF2 and UPF3 in this process has recently been questioned.
In fact, Ivanov and co-workers [53] showed that SMG-1-dependent
phosphorylation of UPF1 can be stimulated independently by UPF2
or UPF3b, which is consistent with previous data reporting UPF2-
and UPF3b-independent NMD [42–44]. In addition, the reported
EJC-independent NMD also challenged the requirement of DECID
formation for UPF1 phosphorylation.
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The mechanism of PTC deﬁnition has been, until now, pointed
out as the most notorious difference concerning the NMD pathway
between mammals and invertebrates. Indeed, only in mammalian
cells a splicing-dependent signal seems to be involved in PTC def-
inition. In yeast, PTC deﬁnition is independent of exon boundaries,
which is consistent with the fact that most yeast genes lack introns
[54]. Also, with the exception of the REF/Aly proteins, there are no
identiﬁable orthologs for the EJC components in this organism [54].
Similarly, exon–exon junctions are not used to deﬁne PTCs in
either C. elegans or D. melanogaster [55,56]. Notably, although the
splicing and NMD machineries are conserved in D. melanogaster,
the NMD in this organism was shown to occur independently of
EJC components and PTC-containing transcripts that derive from
intronless genes were found to be NMD-competent [56]. Likewise,
NMD in C. elegans can be triggered by intronless reporters and, con-
sistently, EJC components such as Y14 and eIF4AIII are not essen-
tial for NMD in this organism [55]. In plants, although NMD can
be triggered by PTC-containing mRNAs derived from intronless
genes, exon–exon boundaries can also elicit efﬁcient NMD when
inserted downstream of a stop codon [57].
The involvement of splicing and EJC components in the mam-
malian NMD mechanism, however, led to the formulation of a
model for PTC deﬁnition in which EJCs were pointed out as the
‘‘marks” used to discriminate premature from normal termination.
In this way, EJCs assemble during splicing next to each exon–exon
junction and serve as anchoring point for the NMD factors UPF2
and UPF3 [37,39]. In addition, several lines of evidence indicate
that mammalian NMD is triggered during what has been called
‘‘the pioneer round of translation”, while the mRNA is still bound
to the nuclear cap-binding complex, which consists of the hetero-
dimer formed by CBP20 and CBP80 [4,5]. It is also postulated that
the translation machinery, during this initial round, displaces the
EJCs associated with the transcript as it proceeds with elongation
[5]. Hence, if translation termination occurs at a PTC located more
than 50–54 nt upstream the last exon–exon junction, at least one
EJC will remain associated with the transcript. The retention of
one or more competent EJCs will allow the interplay between this
complex and the terminating ribosome. This interplay is accom-
plished by the interacting NMD effectors UPF1 and SMG-1, which
associate with translation release factors [51] and UPF2:UPF3,
associated with the EJC [20]. As a result of surveillance complex
assembly, the NMD is triggered and transcripts are committed to
rapid decay [5,7]. On the other hand, in mRNAs that do not harbor
a PTC, or if the PTC is located downstream or too close to the last
EJC, the terminating ribosome reaches the stop codon having dis-
placed all the EJCs present in the transcript and, consequently,
NMD is not activated [5].
Nevertheless, recent data has challenged the requirement for
splicing and EJCs in mammalian NMD activation: NMD can occur
in the absence of splicing or downstream EJCs and the presence of
a 30UTR intron is not sufﬁcient to deﬁne a stop codon as premature.
This suggests that the mechanism of PTC deﬁnition could be more
closely conserved between mammals and invertebrates than was
originally thought. In fact, despite the variations in PTC deﬁnition
among the different species, a positional effect of PTC in NMD trig-
gering is generally observed in all organisms: the closer the PTCs
are to the 30 end of the mRNA the lesser the sensitivity of the tran-
script to NMD [7,11]. In yeast, in particular, two alternative models
for PTC deﬁnition have been proposed. One model postulates that
yeast transcripts contain loosely deﬁned downstream sequence ele-
ments (DSEs), which have a function analogous to that of mamma-
lian exon–exon junctions (in yeast, HRP1 is a RNA-binding protein
thought to associate with DSEs, possibly playing a role equivalentto the one of EJC) [58]. The other model, which is called the ‘faux
30UTRmodel’, proposes that in yeast, NMD is activated by the intrin-
sically aberrant nature of the premature translation termination
[59]. Conversely, a proper termination event which, in turn, would
depend on the right positioning of the stop codon relative to the
poly(A)-binding protein (PABP),would impedeNMD to be triggered.
Indeed, it was shown that tethering of PABP downstream of a PTC,
mimics a normal 30UTR and abolishes NMD [59]. Therefore, the dis-
tinguishing feature of natural stops in yeast seems to be their prox-
imity to PABP. Consistently with this model, the majority of yeast
30UTRs are homogeneous in length and aberrant transcripts with
exceptionally long 30UTRs are substrates for NMD [60].
Recent evidences indicate that the yeast ‘faux 30UTR model’ is
likely to be applicable to PTC deﬁnition in other organisms. Indeed,
similarly to what was found in yeast, tethering of cytoplasmic
poly(A)-binding protein 1 (PABPC1) downstream of a PTC also
abolishes NMD in D. melanogaster and native stop codons were
found to elicit NMD when 30UTR length is increased [61]. Never-
theless, in contrast to what is observed in yeast, a large proportion
of D. melanogaster transcripts are not NMD substrates, albeit hav-
ing 30UTRs that are longer than the average [8]. In plants, although
the cis-acting elements involved in PTC deﬁnition remain to be
determined, long 30UTRs were shown to be able to elicit NMD
when inserted downstream of the native stop codon [57].
Remarkably, recent data have emerged supporting a role for
PABPC1 in the NMD pathway of mammalian systems. In fact, the
PTC deﬁnition of EJC-independent NMD seems to rely on the 30UTR
length, depending on the distance between the termination codon
and the PABPC1 – artiﬁcial extension of the 30UTRs of PTC-free Igl,
b-globin or TPI transcripts was shown to result in mRNA destabili-
zation due to NMD [29,30]. Also, the NMD-sensitiveness of a termi-
nation codon was shown to be modulated by spatial
rearrangements of the 30UTR [29]. In addition, NMD can be im-
paired by tethering PABPC1 in the vicinity of an NMD-competent
PTC, even in the presence of a downstream EJC [29,30,53,62]. These
results also indicate that PABPC1 is able to superimpose its inhib-
itory effect over EJCs on NMD activation provided that PABPC1 is
favorably located relative to the PTC.
According to the yeast faux 30UTR model, the inhibitory effect of
PABP on NMD is a direct consequence of its effect on stimulating a
proper translation termination. In fact, the PABP, was shown to be
able to associate with the terminating ribosome via its interaction
with the translation termination factor eRF3 [63]. Similar to that
described in yeast, recent results in mammals indicate that PABPC1
has an effect in stimulating the efﬁciency of translation termina-
tion: while UPF1 knockdown decreases the level of read through
at all three stop codons, PABPC1 depletion increases these levels
[53]. This suggests that UPF1 and PABPC1 have antagonistic effects
on translation termination efﬁciency that could be correlated with
their respective stimulatory and inhibitory effects on NMD. Fur-
thermore, it was also shown, in vitro, that PABPC1 is able to impair
the interaction between UPF1 and eRF3, which is consistent with
NMD being impaired when the translation termination event oc-
curs proximal to PABPC1 [30]. This might as well explain the
NMD resistance observed in transcripts harboring AUG-proximal
PTCs. In fact, PABPC1 can bind simultaneously to the cap-associ-
ated eIF4G and to the poly(A) tail [63] and this dual binding has
the potential to bring the PABPC1 into close proximity with 50
structures in the mRNA. In the context of an AUG-proximal PTC,
the inherent nature of an extremely early termination event may
be sufﬁcient to maintain PABPC1 favorably located to be able to
superimpose its inhibitory effect on NMD activation, despite the
presence of downstream EJCs. In this way, one can envision a
competition mechanism, in which eRF3, depending on the position
of the PTC, interacts with UPF1 in a way that results in NMD
Fig. 1. A model for surveillance complex assembly and NMD triggering. Based on
recent data, it is proposed that NMD is triggered as a consequence of two
antagonistic signals that can act on the translation termination event: UPF1
promotes NMD activation and PABPC1 promotes a normal termination event, acting
as an NMD repressor. If PABPC1 is favorably located to interact with the termination
complex it impairs the association of UPF1, repressing NMD triggering (A). This can
occur even in the presence of downstream EJCs, for example, when the PTC is AUG-
proximal (B). Conversely, when the interaction between PABPC1 and the termina-
tion complex is not favorable, there is an increased possibility for dephosphorylated
UPF1, together with SMG-1, to be retained in association with the termination
complex, forming the complex called SURF. This may lead to NMD activation even
in the absence of downstream EJCs (C). The downstream EJCs are likely to act as
NMD enhancers, possibly by locally concentrating UPF2/UPF3b in association with
the mRNP (D). In both cases (C and D), SMG-1-mediated phosphorylation of UPF1 is
induced, which recruits SMG-7/SMG-5 and/or SMG-6, together with PP2A. The
decay of the PTC-containing transcript is triggered by SMG-7 alone or together with
SMG-6, possibly by mediating the recruitment of the decay machinery (E). The
association of SMGs and PP2A would also trigger the dephosphorylation of UPF1,
which allows the recycling of the NMD factors for another round of surveillance (E).
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limited association of UPF1 with the mRNP. Consistent with this
hypothesis, in our studies, we observed that NMD-resistant AUG-
proximal nonsense-mutated transcripts fail to bind UPF1 as efﬁ-
ciently as those that are NMD-sensitive [62].
Although the relative position of PABP to a PTC seems now to be
a critical feature for PTC deﬁnition among different species, it
should be noted, however, that there is also evidence indicating
that PTC deﬁnition is not likely to rely exclusively on this determi-
nant. In fact, it was recently shown in yeast that NMD occurs on
unadenylated transcripts or in a mutant strain that lacks PABP
[64], indicating that in the absence of PABP or a poly(A) tail, the
proper distinction between a PTC and a normal stop codon is still
able to occur. Although this does not disqualify PABPC1 as a sup-
pressor of the NMD pathway, it indicates that other molecular sig-
nals may be involved in PTC deﬁnition. In mammals this signal was
for long attributed to EJCs. Nonetheless, recent studies have shown
that these are neither sufﬁcient nor required for NMD activation
[30]. Yet, EJCs do act as NMD enhancers, since the insertion of an
intron into the 30UTR of an mRNA already committed to EJC-inde-
pendent NMD enhances its degradation [30]. Thus, the effect ex-
erted by PABPC1 on NMD inhibition, when favorably positioned
relatively to a PTC, does not exclude that EJCs still play a relevant
role in NMD triggering in mammals. Rather, it indicates that both
PABPC1 and the EJCs participate in this mechanism, in which the
EJC can act as an enhancer while PABPC1 can act as an NMD repres-
sor. Consistent with the contrasting effects of the EJCs and PABPC1
on NMD activation, it was shown that UPF factors co-immunopuri-
fy with proteins involved in 30 ? 50 mRNA decay, such as the
poly(A)-speciﬁc ribonuclease (PARN) [65], while PABPC1 inhibits
the deadenylating activity of this exoribonuclease [66,67]. This
suggests that an inhibitory effect of PABPC1 on 30 ? 50 mRNA deg-
radation might contribute to its suppressive effect on NMD.
Taking together all the recent evidence obtained in the NMD
pathways in higher eukaryotes, a new model for the mechanism
that couples the recognition of a PTC to the assembly of the surveil-
lance complex and NMD triggering can be envisioned (Fig. 1). The
discrimination between a normal and a premature termination
event is considered to be the outcome of the combination of antag-
onistic signals. At a translation termination event, PABPC1 and
UPF1 compete for the interaction with the termination complex.
If PABPC1 is favorably located to interact with this complex, it
would promote a normal termination event and, at the same time,
impair the association of UPF1, repressing NMD triggering
(Fig. 1A). This can occur even in the presence of downstream EJCs
(Fig. 1B). On the other hand, when the interaction between PABPC1
and the termination complex is not favorable, there is an increased
possibility for the dephosphorylated UPF1, together with SMG-1, to
be retained in association with the termination complex, forming
the complex called SURF [51] (Fig. 1C). At this step, a second signal
that will induce NMD triggering, is likely to be required. This sec-
ond signal might be the interaction between UPF1 and UPF2 and/or
UPF3b that will induce SMG-1-mediated phosphorylation of UPF1
[35,50,53]. The presence of downstream EJCs is possible to enhance
this interaction, since they can work as binding platforms for UPF2
and/or UPF3b, locally concentrating these factors in association
with the mRNP (Fig. 1D). The interaction between UPF1 and
UPF2 and/or UPF3b, however, is likely to still be able to occur de-
spite the absence of downstream EJCs, as typiﬁed by EJC-indepen-
dent NMD (Fig. 1C). UPF1, once phosphorylated, is able to recruit
one or both complexes that most likely comprise SMG-7 associated
with SMG-5 and PP2A or SMG-6 associated with PP2A
[11,36,45,46]. Induction of the transcript decay is then carried
out by SMG-7 alone or together with SMG-6, possibly by mediating
the recruitment of the decay machinery [47,49]. The association of
SMGs and PP2A would also trigger the dephosphorylation of UPF1,which could allow the recycling of the NMD factors for another
round of surveillance [11,36,45] (Fig. 1E).
6. Final remarks
Even though much progress has been made in the identiﬁcation
of the mechanistic pathways involved in mammalian NMD, the
molecular basis of NMD is not yet completely known. Here, we give
a perspective about what is described for the mammalian mecha-
nism of NMD, with special emphasis on the new ﬁndings that de-
scribe the NMD players, physical parameters and mechanistic
pathways involved in PTC deﬁnition. We explore some recent data
showing that PTC identiﬁcation seems to depend on the physical
distance between the PTC and PABPC1, as PABPC1 and UPF1, both
compete for the interaction with the eRF3 at the terminating
504 A.L. Silva, L. Romão / FEBS Letters 583 (2009) 499–505ribosome – if PABPC1 is in close proximity to the PTC, it seems to
function as an NMD repressor. Studies in yeast, nematode worm,
fruitﬂy and human cells evidences a conservation of this effect
and outlines a basic mechanism that might provide targets for
new therapeutic strategies for genetic disorders caused by PTC-
generating mutations.Acknowledgements
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